Loading stock data…
Loading stock data…
US$4.05
Get one email when ORMP crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-0.25%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.6
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.00
Bearish momentumMACD below its signal line (0.06).
50-day average
4.14
Price belowShort-term trend reference.
200-day average
3.35
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Oramed Pharmaceuticals Inc. is a biotechnology company focused on the research and development of oral drug delivery systems. The primary purpose of the company is to transform injectable treatments into oral forms, thereby aiming to enhance patient convenience and compliance. A notable highlight of Oramed's innovation is its proprietary Protein Oral Delivery (POD) technology, which facilitates the oral administration of proteins that traditionally require injections. This innovative approach ha…
oramed.com0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-06-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-05-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-04-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2025-03-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-26 | — | 0.25 | — |
| 2026-02-25 | 0.16 | 0.43 | ✓ Beat |
| 2025-12-11 | -2.13 | -0.32 | ✓ Beat |
| 2025-11-28 | 2.94 | 2.57 | ✗ Miss |
| 2025-11-13 | -0.04 | 1.13 | ✓ Beat |
| 2025-10-14 | 0.45 | 0.51 | ✓ Beat |
| 2025-08-14 | -0.04 | 0.31 | ✓ Beat |
| 2025-05-15 | -0.01 | -0.19 | ✗ Miss |
Companies in the same industry, via Finnhub
| Ex-dividend date | Amount | Payment date |
|---|---|---|
| 2026-01-16 | 0.25 | — |